Alexander Barker
Concepts (349)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aortic Valve | 67 | 2024 | 425 | 11.340 |
Why?
| Heart Valve Diseases | 53 | 2024 | 170 | 9.880 |
Why?
| Hemodynamics | 77 | 2024 | 1095 | 8.490 |
Why?
| Magnetic Resonance Angiography | 43 | 2025 | 237 | 8.120 |
Why?
| Aorta | 55 | 2024 | 410 | 7.860 |
Why?
| Imaging, Three-Dimensional | 56 | 2025 | 559 | 6.510 |
Why?
| Magnetic Resonance Imaging | 80 | 2025 | 3348 | 5.760 |
Why?
| Blood Flow Velocity | 74 | 2024 | 413 | 5.720 |
Why?
| Magnetic Resonance Imaging, Cine | 35 | 2024 | 181 | 4.940 |
Why?
| Image Interpretation, Computer-Assisted | 30 | 2025 | 253 | 4.270 |
Why?
| Aorta, Thoracic | 23 | 2023 | 260 | 4.080 |
Why?
| Aortic Diseases | 23 | 2024 | 112 | 3.980 |
Why?
| Aortic Valve Stenosis | 22 | 2022 | 291 | 3.620 |
Why?
| Stress, Mechanical | 33 | 2024 | 470 | 3.030 |
Why?
| Aortic Aneurysm, Thoracic | 8 | 2023 | 128 | 2.120 |
Why?
| Pulmonary Artery | 17 | 2024 | 1091 | 2.060 |
Why?
| Regional Blood Flow | 22 | 2024 | 462 | 2.030 |
Why?
| Predictive Value of Tests | 32 | 2024 | 1967 | 1.990 |
Why?
| Shear Strength | 15 | 2024 | 68 | 1.980 |
Why?
| Fetal Heart | 3 | 2024 | 53 | 1.800 |
Why?
| Ventricular Function, Left | 16 | 2024 | 526 | 1.750 |
Why?
| Vascular Stiffness | 17 | 2024 | 479 | 1.700 |
Why?
| Heart Ventricles | 17 | 2024 | 778 | 1.570 |
Why?
| Echocardiography, Doppler | 5 | 2024 | 111 | 1.540 |
Why?
| Reproducibility of Results | 32 | 2024 | 3042 | 1.430 |
Why?
| Models, Cardiovascular | 11 | 2021 | 193 | 1.400 |
Why?
| Image Enhancement | 12 | 2022 | 165 | 1.380 |
Why?
| Perfusion Imaging | 14 | 2024 | 57 | 1.350 |
Why?
| Pregnancy Trimester, Third | 3 | 2025 | 105 | 1.310 |
Why?
| Tetralogy of Fallot | 8 | 2022 | 79 | 1.240 |
Why?
| Humans | 181 | 2025 | 128896 | 1.180 |
Why?
| Echocardiography, Four-Dimensional | 3 | 2024 | 8 | 1.110 |
Why?
| Female | 119 | 2025 | 68162 | 1.080 |
Why?
| Aortic Coarctation | 8 | 2025 | 82 | 1.060 |
Why?
| Ultrasonography, Prenatal | 3 | 2025 | 266 | 1.050 |
Why?
| Contrast Media | 11 | 2022 | 387 | 1.030 |
Why?
| Terminology as Topic | 4 | 2024 | 204 | 1.030 |
Why?
| Hypertension, Pulmonary | 11 | 2023 | 1876 | 1.000 |
Why?
| Image Processing, Computer-Assisted | 11 | 2025 | 739 | 0.990 |
Why?
| Male | 116 | 2024 | 63146 | 0.990 |
Why?
| Heart Valve Prosthesis Implantation | 6 | 2019 | 198 | 0.960 |
Why?
| Gestational Age | 3 | 2025 | 857 | 0.920 |
Why?
| Fontan Procedure | 8 | 2024 | 169 | 0.920 |
Why?
| Myocardial Perfusion Imaging | 8 | 2020 | 36 | 0.910 |
Why?
| Adult | 70 | 2025 | 35361 | 0.910 |
Why?
| Retrospective Studies | 47 | 2025 | 14546 | 0.880 |
Why?
| Ventricular Function, Right | 12 | 2024 | 274 | 0.870 |
Why?
| Heart Defects, Congenital | 11 | 2023 | 752 | 0.860 |
Why?
| Iothalamic Acid | 1 | 2022 | 5 | 0.830 |
Why?
| Observer Variation | 6 | 2023 | 321 | 0.800 |
Why?
| Coronary Circulation | 10 | 2020 | 138 | 0.800 |
Why?
| Cardiac-Gated Imaging Techniques | 9 | 2020 | 17 | 0.780 |
Why?
| Middle Aged | 61 | 2024 | 30977 | 0.770 |
Why?
| Young Adult | 40 | 2024 | 12286 | 0.750 |
Why?
| Cardiac Surgical Procedures | 5 | 2020 | 501 | 0.740 |
Why?
| Pulmonary Circulation | 6 | 2019 | 429 | 0.730 |
Why?
| Hydrodynamics | 4 | 2022 | 40 | 0.730 |
Why?
| Sensitivity and Specificity | 15 | 2016 | 1840 | 0.720 |
Why?
| Problem-Based Learning | 1 | 2021 | 77 | 0.720 |
Why?
| Ventricular Dysfunction, Right | 6 | 2022 | 226 | 0.720 |
Why?
| Electrocardiography | 4 | 2020 | 602 | 0.690 |
Why?
| Reference Values | 9 | 2024 | 791 | 0.680 |
Why?
| Anesthesia | 1 | 2022 | 130 | 0.680 |
Why?
| Bicuspid | 2 | 2018 | 16 | 0.680 |
Why?
| Nuclear Physics | 6 | 2014 | 13 | 0.660 |
Why?
| Ventricular Dysfunction, Left | 5 | 2020 | 387 | 0.660 |
Why?
| Arterial Pressure | 6 | 2019 | 118 | 0.660 |
Why?
| Child | 41 | 2024 | 20824 | 0.660 |
Why?
| Algorithms | 12 | 2025 | 1626 | 0.640 |
Why?
| Aged | 39 | 2024 | 22035 | 0.620 |
Why?
| Adolescent | 39 | 2024 | 20197 | 0.590 |
Why?
| Case-Control Studies | 20 | 2023 | 3334 | 0.590 |
Why?
| Pulse Wave Analysis | 9 | 2023 | 252 | 0.580 |
Why?
| Severity of Illness Index | 11 | 2019 | 2767 | 0.550 |
Why?
| Hypoplastic Left Heart Syndrome | 3 | 2024 | 116 | 0.540 |
Why?
| Cardiac Imaging Techniques | 8 | 2021 | 21 | 0.520 |
Why?
| Models, Theoretical | 7 | 2017 | 550 | 0.520 |
Why?
| Aortography | 3 | 2021 | 51 | 0.520 |
Why?
| C-Peptide | 2 | 2014 | 163 | 0.520 |
Why?
| Aortic Aneurysm | 6 | 2024 | 64 | 0.510 |
Why?
| Prospective Studies | 18 | 2024 | 7060 | 0.500 |
Why?
| Gadolinium DTPA | 2 | 2018 | 49 | 0.490 |
Why?
| Systole | 9 | 2022 | 190 | 0.490 |
Why?
| Kidney | 1 | 2022 | 1330 | 0.490 |
Why?
| Feasibility Studies | 10 | 2019 | 859 | 0.470 |
Why?
| Aging | 2 | 2015 | 1767 | 0.450 |
Why?
| Arteriosclerosis | 1 | 2014 | 86 | 0.450 |
Why?
| Elementary Particles | 4 | 2014 | 11 | 0.440 |
Why?
| Cardiovascular Diseases | 7 | 2024 | 2013 | 0.440 |
Why?
| Hemorheology | 1 | 2013 | 21 | 0.440 |
Why?
| Dilatation, Pathologic | 7 | 2024 | 61 | 0.440 |
Why?
| Age Factors | 11 | 2024 | 3133 | 0.430 |
Why?
| Stroke Volume | 9 | 2022 | 587 | 0.430 |
Why?
| Marfan Syndrome | 3 | 2018 | 42 | 0.430 |
Why?
| Multidetector Computed Tomography | 1 | 2013 | 33 | 0.420 |
Why?
| Computer Simulation | 6 | 2021 | 943 | 0.420 |
Why?
| Insulin Antibodies | 1 | 2013 | 104 | 0.420 |
Why?
| Diabetes Mellitus, Type 1 | 6 | 2024 | 3601 | 0.410 |
Why?
| Norwood Procedures | 2 | 2024 | 29 | 0.410 |
Why?
| Hyperventilation | 1 | 2012 | 9 | 0.400 |
Why?
| Insulin-Secreting Cells | 2 | 2014 | 363 | 0.400 |
Why?
| Pilot Projects | 10 | 2022 | 1545 | 0.390 |
Why?
| Awareness | 1 | 2012 | 98 | 0.370 |
Why?
| Acceleration | 1 | 2011 | 30 | 0.370 |
Why?
| Heart Valve Prosthesis | 4 | 2017 | 132 | 0.370 |
Why?
| Vascular Remodeling | 5 | 2019 | 186 | 0.370 |
Why?
| Child, Preschool | 16 | 2022 | 10457 | 0.350 |
Why?
| Phantoms, Imaging | 5 | 2022 | 139 | 0.350 |
Why?
| Mitral Valve Stenosis | 2 | 2022 | 22 | 0.340 |
Why?
| Electroencephalography | 1 | 2012 | 387 | 0.330 |
Why?
| Fetus | 2 | 2025 | 764 | 0.330 |
Why?
| Phenotype | 9 | 2021 | 3059 | 0.320 |
Why?
| Biomechanical Phenomena | 6 | 2023 | 784 | 0.320 |
Why?
| Cardiovascular System | 2 | 2023 | 138 | 0.300 |
Why?
| Postoperative Complications | 5 | 2020 | 2494 | 0.280 |
Why?
| Artifacts | 3 | 2025 | 124 | 0.280 |
Why?
| Heart Function Tests | 2 | 2019 | 61 | 0.270 |
Why?
| Ventricular Remodeling | 5 | 2022 | 255 | 0.270 |
Why?
| Principal Component Analysis | 2 | 2024 | 185 | 0.260 |
Why?
| Time Factors | 13 | 2024 | 6568 | 0.260 |
Why?
| Cross-Sectional Studies | 7 | 2024 | 5032 | 0.250 |
Why?
| Infant, Newborn | 5 | 2023 | 5704 | 0.240 |
Why?
| Blood Vessel Prosthesis Implantation | 2 | 2019 | 200 | 0.240 |
Why?
| Blood Circulation | 1 | 2024 | 41 | 0.240 |
Why?
| Hypoglycemic Agents | 1 | 2013 | 1206 | 0.240 |
Why?
| Biomarkers | 7 | 2023 | 3874 | 0.230 |
Why?
| Cross-Over Studies | 2 | 2024 | 513 | 0.230 |
Why?
| Pulmonary Valve Insufficiency | 2 | 2022 | 42 | 0.230 |
Why?
| Follow-Up Studies | 7 | 2021 | 4917 | 0.230 |
Why?
| Placental Circulation | 1 | 2025 | 63 | 0.230 |
Why?
| Viscosity | 3 | 2019 | 90 | 0.230 |
Why?
| Diffusion Magnetic Resonance Imaging | 1 | 2025 | 94 | 0.230 |
Why?
| Myocardial Contraction | 3 | 2020 | 336 | 0.230 |
Why?
| Echocardiography | 6 | 2022 | 634 | 0.230 |
Why?
| Marketing | 1 | 2024 | 28 | 0.230 |
Why?
| Microvessels | 1 | 2025 | 79 | 0.230 |
Why?
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2024 | 5 | 0.220 |
Why?
| Ultrasonography | 3 | 2017 | 727 | 0.220 |
Why?
| Rheology | 2 | 2017 | 90 | 0.220 |
Why?
| Cardiomyopathy, Hypertrophic | 2 | 2015 | 129 | 0.220 |
Why?
| Elementary Particle Interactions | 2 | 2013 | 4 | 0.210 |
Why?
| Prenatal Diagnosis | 1 | 2025 | 189 | 0.210 |
Why?
| Insulin | 1 | 2013 | 2311 | 0.210 |
Why?
| Tomography, X-Ray Computed | 3 | 2023 | 2530 | 0.200 |
Why?
| Carotid Arteries | 2 | 2017 | 207 | 0.200 |
Why?
| Infant | 9 | 2024 | 8994 | 0.200 |
Why?
| Respiratory-Gated Imaging Techniques | 3 | 2018 | 10 | 0.200 |
Why?
| Anesthesia, General | 1 | 2022 | 53 | 0.200 |
Why?
| Mitral Valve Insufficiency | 1 | 2022 | 79 | 0.190 |
Why?
| Biomedical Engineering | 1 | 2021 | 24 | 0.190 |
Why?
| Coronary Vessels | 2 | 2021 | 252 | 0.190 |
Why?
| Prenatal Care | 1 | 2024 | 272 | 0.190 |
Why?
| Body Fluids | 1 | 2021 | 61 | 0.190 |
Why?
| Pulmonary Disease, Chronic Obstructive | 2 | 2021 | 985 | 0.190 |
Why?
| Healthy Volunteers | 3 | 2017 | 204 | 0.190 |
Why?
| Glomerular Filtration Rate | 2 | 2022 | 684 | 0.180 |
Why?
| Respiration | 1 | 2022 | 191 | 0.180 |
Why?
| Cell-Free Nucleic Acids | 1 | 2021 | 30 | 0.180 |
Why?
| Bioprosthesis | 3 | 2015 | 40 | 0.180 |
Why?
| Glycopeptides | 1 | 2021 | 44 | 0.180 |
Why?
| Creatinine | 1 | 2022 | 485 | 0.180 |
Why?
| Body Surface Area | 1 | 2020 | 34 | 0.170 |
Why?
| Natriuretic Peptide, Brain | 1 | 2021 | 101 | 0.170 |
Why?
| Consensus | 5 | 2021 | 644 | 0.170 |
Why?
| Aortic Valve Insufficiency | 2 | 2018 | 47 | 0.170 |
Why?
| Diagnostic Imaging | 2 | 2020 | 327 | 0.170 |
Why?
| Sinus of Valsalva | 1 | 2019 | 11 | 0.170 |
Why?
| Intracranial Aneurysm | 1 | 2021 | 95 | 0.170 |
Why?
| Cardiac Catheterization | 6 | 2023 | 583 | 0.170 |
Why?
| Mechanotransduction, Cellular | 1 | 2021 | 110 | 0.170 |
Why?
| Radiography | 3 | 2024 | 863 | 0.170 |
Why?
| Pregnancy | 4 | 2025 | 6247 | 0.160 |
Why?
| Fetal Growth Retardation | 1 | 2025 | 542 | 0.160 |
Why?
| Blood Volume | 2 | 2016 | 60 | 0.160 |
Why?
| Echocardiography, Doppler, Color | 2 | 2022 | 43 | 0.160 |
Why?
| Aorta, Abdominal | 2 | 2015 | 42 | 0.150 |
Why?
| Elastic Tissue | 1 | 2018 | 8 | 0.150 |
Why?
| Tricuspid Valve | 2 | 2015 | 28 | 0.150 |
Why?
| Placenta | 1 | 2025 | 706 | 0.150 |
Why?
| Neurobehavioral Manifestations | 1 | 1998 | 1 | 0.150 |
Why?
| Sleep | 1 | 2024 | 657 | 0.150 |
Why?
| Endothelium, Vascular | 2 | 2016 | 917 | 0.150 |
Why?
| Hematopoietic Stem Cell Transplantation | 1 | 2024 | 576 | 0.150 |
Why?
| Muscarinic Antagonists | 1 | 1998 | 27 | 0.150 |
Why?
| Turner Syndrome | 1 | 2018 | 51 | 0.150 |
Why?
| Prognosis | 7 | 2021 | 3787 | 0.150 |
Why?
| Pulmonary Wedge Pressure | 1 | 2017 | 67 | 0.140 |
Why?
| Alcohol Drinking | 1 | 2024 | 742 | 0.140 |
Why?
| Alcoholism | 1 | 2024 | 759 | 0.140 |
Why?
| Mucocutaneous Lymph Node Syndrome | 1 | 2018 | 88 | 0.140 |
Why?
| Heart Transplantation | 1 | 2023 | 713 | 0.140 |
Why?
| Blood Vessel Prosthesis | 1 | 2017 | 125 | 0.140 |
Why?
| Mesons | 2 | 2014 | 8 | 0.130 |
Why?
| Peptide Fragments | 1 | 2021 | 694 | 0.130 |
Why?
| Motion | 3 | 2025 | 100 | 0.130 |
Why?
| Thoracic Surgery | 1 | 2018 | 133 | 0.130 |
Why?
| Blood Pressure | 3 | 2019 | 1743 | 0.130 |
Why?
| Endocardium | 1 | 2016 | 32 | 0.130 |
Why?
| Mitral Valve | 1 | 2017 | 101 | 0.130 |
Why?
| Heart Rate | 1 | 2020 | 807 | 0.130 |
Why?
| Arteries | 1 | 2018 | 268 | 0.130 |
Why?
| Disease Progression | 6 | 2019 | 2603 | 0.130 |
Why?
| Statistics, Nonparametric | 2 | 2012 | 424 | 0.130 |
Why?
| Nitric Oxide | 1 | 2021 | 892 | 0.120 |
Why?
| Analysis of Variance | 3 | 2014 | 1283 | 0.120 |
Why?
| Splanchnic Circulation | 1 | 2015 | 10 | 0.120 |
Why?
| Mitral Valve Annuloplasty | 1 | 2015 | 5 | 0.120 |
Why?
| Preoperative Care | 1 | 2017 | 343 | 0.120 |
Why?
| Cerebrovascular Disorders | 1 | 2016 | 91 | 0.120 |
Why?
| Computed Tomography Angiography | 1 | 2016 | 115 | 0.120 |
Why?
| Cohort Studies | 5 | 2021 | 5394 | 0.120 |
Why?
| Treatment Outcome | 8 | 2024 | 10239 | 0.120 |
Why?
| Biomedical Research | 1 | 2021 | 654 | 0.120 |
Why?
| Angiography | 1 | 2015 | 199 | 0.120 |
Why?
| Databases, Factual | 2 | 2017 | 1289 | 0.120 |
Why?
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2015 | 40 | 0.120 |
Why?
| Chi-Square Distribution | 2 | 2013 | 513 | 0.120 |
Why?
| Neutrons | 1 | 2014 | 9 | 0.120 |
Why?
| Coronary Artery Disease | 1 | 2021 | 695 | 0.110 |
Why?
| Atherosclerosis | 2 | 2021 | 392 | 0.110 |
Why?
| Portal Vein | 1 | 2015 | 106 | 0.110 |
Why?
| Ventricular Outflow Obstruction | 1 | 2014 | 41 | 0.110 |
Why?
| Brain Mapping | 1 | 2017 | 562 | 0.110 |
Why?
| Subtraction Technique | 1 | 2013 | 24 | 0.110 |
Why?
| Heart | 3 | 2023 | 650 | 0.110 |
Why?
| Cerebrovascular Circulation | 1 | 2015 | 223 | 0.110 |
Why?
| Adrenergic beta-Antagonists | 1 | 2016 | 320 | 0.110 |
Why?
| Scleroderma, Systemic | 1 | 2014 | 109 | 0.110 |
Why?
| Carotid Artery, Internal | 1 | 2013 | 41 | 0.110 |
Why?
| Endarterectomy, Carotid | 1 | 2013 | 47 | 0.100 |
Why?
| Multimodal Imaging | 1 | 2013 | 107 | 0.100 |
Why?
| Familial Primary Pulmonary Hypertension | 1 | 2013 | 197 | 0.100 |
Why?
| Europe | 1 | 2013 | 366 | 0.100 |
Why?
| Plaque, Atherosclerotic | 1 | 2013 | 49 | 0.100 |
Why?
| Epilepsy, Partial, Motor | 1 | 2012 | 1 | 0.100 |
Why?
| Epilepsy, Absence | 1 | 2012 | 5 | 0.100 |
Why?
| Protons | 1 | 2013 | 80 | 0.100 |
Why?
| Carotid Stenosis | 1 | 2013 | 85 | 0.100 |
Why?
| Femoral Artery | 1 | 2013 | 176 | 0.100 |
Why?
| Alzheimer Disease | 1 | 1998 | 509 | 0.100 |
Why?
| Age of Onset | 1 | 2013 | 494 | 0.100 |
Why?
| Fasting | 1 | 2013 | 265 | 0.100 |
Why?
| Pulmonary Embolism | 1 | 2014 | 211 | 0.100 |
Why?
| Systematized Nomenclature of Medicine | 2 | 2021 | 13 | 0.090 |
Why?
| Endothelial Cells | 1 | 2016 | 734 | 0.090 |
Why?
| Aged, 80 and over | 4 | 2015 | 7050 | 0.090 |
Why?
| Dilatation | 2 | 2021 | 62 | 0.080 |
Why?
| Vasodilation | 1 | 2013 | 480 | 0.080 |
Why?
| Longitudinal Studies | 2 | 2014 | 2668 | 0.080 |
Why?
| Diastole | 2 | 2020 | 151 | 0.080 |
Why?
| RNA | 1 | 2016 | 877 | 0.080 |
Why?
| Dose-Response Relationship, Drug | 1 | 2013 | 1968 | 0.080 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2023 | 2421 | 0.080 |
Why?
| Seizures | 1 | 2012 | 395 | 0.080 |
Why?
| Risk Factors | 6 | 2020 | 9792 | 0.080 |
Why?
| Patient-Specific Modeling | 2 | 2020 | 39 | 0.080 |
Why?
| Swine | 3 | 2016 | 740 | 0.080 |
Why?
| Linear Models | 3 | 2017 | 817 | 0.080 |
Why?
| Genetic Predisposition to Disease | 1 | 2016 | 2270 | 0.070 |
Why?
| Heart-Assist Devices | 1 | 2013 | 529 | 0.070 |
Why?
| Calibration | 2 | 2017 | 137 | 0.070 |
Why?
| Peripheral Arterial Disease | 1 | 2013 | 458 | 0.070 |
Why?
| Body Mass Index | 1 | 2014 | 2244 | 0.060 |
Why?
| Blood Volume Determination | 2 | 2016 | 5 | 0.060 |
Why?
| Myocardial Infarction | 1 | 2013 | 1031 | 0.060 |
Why?
| Vena Cava, Inferior | 2 | 2016 | 68 | 0.060 |
Why?
| Elasticity | 2 | 2017 | 202 | 0.060 |
Why?
| Stroke | 1 | 2013 | 1111 | 0.060 |
Why?
| Organometallic Compounds | 2 | 2018 | 104 | 0.060 |
Why?
| Alcoholic Beverages | 1 | 2024 | 19 | 0.060 |
Why?
| Actigraphy | 1 | 2024 | 88 | 0.050 |
Why?
| Neural Conduction | 1 | 2024 | 82 | 0.050 |
Why?
| Technology | 1 | 2024 | 83 | 0.050 |
Why?
| Pulsatile Flow | 2 | 2015 | 60 | 0.050 |
Why?
| Risk Assessment | 3 | 2018 | 3286 | 0.050 |
Why?
| Bromocriptine | 1 | 2022 | 27 | 0.050 |
Why?
| Prevalence | 2 | 2023 | 2540 | 0.050 |
Why?
| Endothelium-Dependent Relaxing Factors | 1 | 2021 | 17 | 0.050 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2023 | 510 | 0.050 |
Why?
| Collagen | 1 | 2023 | 433 | 0.040 |
Why?
| Longevity | 1 | 2022 | 150 | 0.040 |
Why?
| Stents | 2 | 2015 | 518 | 0.040 |
Why?
| Sex Factors | 2 | 2017 | 1947 | 0.040 |
Why?
| Printing, Three-Dimensional | 1 | 2021 | 81 | 0.040 |
Why?
| Diabetic Cardiomyopathies | 1 | 2020 | 35 | 0.040 |
Why?
| Heart Failure | 1 | 2013 | 2142 | 0.040 |
Why?
| Biological Transport | 1 | 2021 | 394 | 0.040 |
Why?
| Electrophysiological Phenomena | 1 | 2019 | 50 | 0.040 |
Why?
| Obesity | 2 | 2023 | 2844 | 0.040 |
Why?
| Double-Blind Method | 1 | 2024 | 1858 | 0.040 |
Why?
| Administration, Inhalation | 1 | 2021 | 675 | 0.040 |
Why?
| Hypertrophy, Right Ventricular | 1 | 2020 | 145 | 0.040 |
Why?
| Mechanical Phenomena | 1 | 2019 | 81 | 0.040 |
Why?
| Overweight | 1 | 2023 | 522 | 0.040 |
Why?
| User-Computer Interface | 1 | 2019 | 147 | 0.040 |
Why?
| Models, Biological | 1 | 2006 | 1702 | 0.040 |
Why?
| Gadolinium | 1 | 2018 | 77 | 0.040 |
Why?
| Anastomosis, Surgical | 1 | 2018 | 149 | 0.040 |
Why?
| Microscopy, Phase-Contrast | 1 | 2017 | 16 | 0.040 |
Why?
| Myocardium | 1 | 2023 | 981 | 0.040 |
Why?
| Signal-To-Noise Ratio | 1 | 2017 | 62 | 0.040 |
Why?
| Vascular Resistance | 1 | 2019 | 373 | 0.040 |
Why?
| Perfusion | 1 | 2017 | 191 | 0.030 |
Why?
| Preoperative Period | 1 | 2017 | 112 | 0.030 |
Why?
| Vena Cava, Superior | 1 | 2016 | 22 | 0.030 |
Why?
| Genomic Library | 1 | 2016 | 15 | 0.030 |
Why?
| Reaction Time | 1 | 1998 | 407 | 0.030 |
Why?
| Memory | 1 | 1998 | 231 | 0.030 |
Why?
| DNA Methylation | 1 | 2021 | 600 | 0.030 |
Why?
| Tissue Inhibitor of Metalloproteinases | 1 | 2015 | 17 | 0.030 |
Why?
| Extracellular Fluid | 1 | 2015 | 31 | 0.030 |
Why?
| Elastin | 1 | 2015 | 78 | 0.030 |
Why?
| Liver Circulation | 1 | 2015 | 19 | 0.030 |
Why?
| Splenic Artery | 1 | 2015 | 14 | 0.030 |
Why?
| Risk | 1 | 2018 | 866 | 0.030 |
Why?
| Mesenteric Artery, Superior | 1 | 2015 | 15 | 0.030 |
Why?
| Pedigree | 1 | 2016 | 491 | 0.030 |
Why?
| Energy Metabolism | 1 | 2021 | 837 | 0.030 |
Why?
| Hepatic Artery | 1 | 2015 | 58 | 0.030 |
Why?
| Heart Atria | 1 | 2016 | 126 | 0.030 |
Why?
| Matrix Metalloproteinases | 1 | 2015 | 90 | 0.030 |
Why?
| ROC Curve | 1 | 2016 | 500 | 0.030 |
Why?
| Postoperative Period | 1 | 2015 | 319 | 0.030 |
Why?
| Cell Count | 1 | 2014 | 316 | 0.030 |
Why?
| Electrons | 1 | 2014 | 78 | 0.030 |
Why?
| Oxygen | 1 | 2018 | 912 | 0.030 |
Why?
| Organ Sparing Treatments | 1 | 2013 | 32 | 0.030 |
Why?
| Prosthesis Design | 1 | 2015 | 321 | 0.030 |
Why?
| Animals | 4 | 2016 | 34628 | 0.030 |
Why?
| Observational Studies as Topic | 1 | 2013 | 108 | 0.030 |
Why?
| Quality Control | 1 | 2013 | 154 | 0.030 |
Why?
| Pericardium | 1 | 2013 | 54 | 0.030 |
Why?
| Blood Pressure Determination | 1 | 2013 | 150 | 0.030 |
Why?
| Sheep | 1 | 2015 | 832 | 0.020 |
Why?
| Survival Rate | 1 | 2017 | 1884 | 0.020 |
Why?
| Thermodynamics | 1 | 2014 | 403 | 0.020 |
Why?
| Recurrence | 1 | 2015 | 1013 | 0.020 |
Why?
| Multivariate Analysis | 1 | 2015 | 1504 | 0.020 |
Why?
| Forecasting | 1 | 2013 | 363 | 0.020 |
Why?
| Meglumine | 1 | 2011 | 14 | 0.020 |
Why?
| United States | 2 | 2018 | 13975 | 0.020 |
Why?
| Abnormalities, Multiple | 1 | 2012 | 178 | 0.020 |
Why?
| Cognition | 1 | 1998 | 1093 | 0.020 |
Why?
| Heart Diseases | 1 | 2013 | 356 | 0.020 |
Why?
| Gene Expression Profiling | 1 | 2016 | 1694 | 0.020 |
Why?
| Scattering, Radiation | 1 | 2006 | 98 | 0.020 |
Why?
| Microbubbles | 1 | 2006 | 48 | 0.020 |
Why?
| Nanotubes | 1 | 2006 | 43 | 0.020 |
Why?
| Particle Size | 1 | 2006 | 351 | 0.010 |
Why?
|
|
Barker's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|